Pacer MSCI World Industry Advantage ETF (GLBL) seeks to track the MSCI World Industry Advantage Index, which measures the performance of developed market stocks selected based on industry-specific fundamental factors. This international equity ETF provides exposure to companies across multiple developed countries outside the U.S.
How It Works
GLBL uses a rules-based methodology that selects stocks from the MSCI World Index based on industry-specific fundamental metrics like profitability, quality, and valuation factors tailored to each sector. The fund employs a passive approach, rebalancing quarterly to maintain alignment with index changes. Holdings are weighted by modified market capitalization after factor screening, typically holding 200-400 stocks across developed international markets including Europe, Japan, and other regions.
Key Features
- Newly launched in September 2024, offering innovative industry-specific factor screening unavailable in traditional broad international ETFs
- Zero expense ratio structure makes it one of the most cost-effective international developed market ETFs available
- Factor-based selection process aims to identify higher-quality companies within each industry rather than simple market-cap weighting
Risks
- This ETF can lose value during international market downturns, potentially declining 25-35% in severe global recessions given developed market equity exposure
- Currency fluctuations between the U.S. dollar and foreign currencies can reduce returns even when underlying stocks perform well
- Factor-based selection may underperform broad market indices during periods when momentum or growth factors dominate quality metrics
Who Should Own This
Best suited as a satellite holding (10-25% of equity allocation) for investors with 3+ year time horizons seeking international diversification beyond U.S. markets. Medium-to-high risk tolerance required due to foreign equity volatility and currency exposure. Appeals to factor-focused investors wanting developed market exposure with quality screening rather than pure market-cap weighting.